Susan E. Critchlow

7.6k total citations
43 papers, 3.4k citations indexed

About

Susan E. Critchlow is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Susan E. Critchlow has authored 43 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 25 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Susan E. Critchlow's work include Cancer, Hypoxia, and Metabolism (23 papers), Metabolomics and Mass Spectrometry Studies (5 papers) and DNA Repair Mechanisms (5 papers). Susan E. Critchlow is often cited by papers focused on Cancer, Hypoxia, and Metabolism (23 papers), Metabolomics and Mass Spectrometry Studies (5 papers) and DNA Repair Mechanisms (5 papers). Susan E. Critchlow collaborates with scholars based in United Kingdom, United States and Singapore. Susan E. Critchlow's co-authors include Stephen P. Jackson, Richard P. Bowater, Anthony Maxwell, Filippos Michopoulos, Paul D. Smith, Clare Murray, Johanna Chiche, Ibtissam Marchiq, Danièle Roux and Marie‐Pierre Simon and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Journal of Molecular Biology.

In The Last Decade

Susan E. Critchlow

42 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Susan E. Critchlow United Kingdom	24	2.7k	1.1k	727	276	202	43	3.4k
Philip L. Lorenzi United States	35	2.5k 0.9×	1.2k 1.0×	679 0.9×	286 1.0×	129 0.6×	109	3.6k
Sybille Mazurek Germany	24	2.3k 0.9×	1.8k 1.6×	537 0.7×	277 1.0×	162 0.8×	45	3.4k
Shufang Liang China	30	1.7k 0.6×	725 0.6×	455 0.6×	363 1.3×	134 0.7×	85	2.6k
Peter Mullen United Kingdom	34	1.9k 0.7×	1.1k 0.9×	773 1.1×	246 0.9×	303 1.5×	84	3.3k
Evette S. Radisky United States	35	2.1k 0.8×	1.2k 1.0×	1.4k 1.9×	332 1.2×	192 1.0×	86	3.8k
Dhirendra K. Simanshu United States	25	3.1k 1.2×	603 0.5×	526 0.7×	230 0.8×	174 0.9×	65	3.8k
Ju‐Gyeong Kang United States	19	2.2k 0.8×	1.0k 0.9×	626 0.9×	175 0.6×	390 1.9×	36	3.1k
Monica Schenone United States	17	2.7k 1.0×	399 0.3×	604 0.8×	345 1.3×	123 0.6×	33	3.5k
Anna Sablina Belgium	29	2.7k 1.0×	717 0.6×	1.1k 1.5×	243 0.9×	167 0.8×	51	3.6k

Countries citing papers authored by Susan E. Critchlow

Since Specialization

Citations

This map shows the geographic impact of Susan E. Critchlow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan E. Critchlow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan E. Critchlow more than expected).

Fields of papers citing papers by Susan E. Critchlow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan E. Critchlow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan E. Critchlow. The network helps show where Susan E. Critchlow may publish in the future.

Co-authorship network of co-authors of Susan E. Critchlow

This figure shows the co-authorship network connecting the top 25 collaborators of Susan E. Critchlow. A scholar is included among the top collaborators of Susan E. Critchlow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan E. Critchlow. Susan E. Critchlow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wigmore, Eleanor M., Stuart C. Williamson, Amanda L. Christie, et al.. (2025). The interplay between FOXO3 and FOXM1 influences sensitivity to AKT inhibition in PIK3CA and PIK3CA/PTEN altered estrogen receptor positive breast cancer. npj Breast Cancer. 11(1). 36–36.

Cherkaoui, Sarah, Jenna Bradley, Susan E. Critchlow, et al.. (2022). A functional analysis of 180 cancer cell lines reveals conserved intrinsic metabolic programs. Molecular Systems Biology. 18(11). e11033–e11033. 19 indexed citations

Carnevalli, Larissa S., Molly A. Taylor, Matthew King, et al.. (2021). Macrophage Activation Status Rather than Repolarization Is Associated with Enhanced Checkpoint Activity in Combination with PI3Kγ Inhibition. Molecular Cancer Therapeutics. 20(6). 1080–1091. 14 indexed citations

Petreuş, Tudor, Elaine Cadogan, Gareth Hughes, et al.. (2021). Tumour-on-chip microfluidic platform for assessment of drug pharmacokinetics and treatment response. Communications Biology. 4(1). 1001–1001. 40 indexed citations

Lynch, James T., Urszula M. Polanska, Oona Delpuech, et al.. (2018). Combined Inhibition of PI3Kβ and mTOR Inhibits Growth of PTEN-null Tumors. Molecular Cancer Therapeutics. 17(11). 2309–2319. 18 indexed citations

Jones, Dylan T., Alessandro Valli, Syed Haider, et al.. (2018). 3D Growth of Cancer Cells Elicits Sensitivity to Kinase Inhibitors but Not Lipid Metabolism Modifiers. Molecular Cancer Therapeutics. 18(2). 376–388. 20 indexed citations

Lynch, James T., Urszula M. Polanska, Oona Delpuech, et al.. (2017). Inhibiting PI3Kβ with AZD8186 Regulates Key Metabolic Pathways in PTEN-Null Tumors. Clinical Cancer Research. 23(24). 7584–7595. 24 indexed citations

Blair, Helen J., Huw D. Thomas, Nicole Phillips, et al.. (2017). Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphoma. Haematologica. 102(7). 1247–1257. 119 indexed citations

Trinidad, Antonio G., Nicky Whalley, Rachel Rowlinson, et al.. (2017). Pyruvate dehydrogenase kinase 4 exhibits a novel role in the activation of mutant KRAS, regulating cell growth in lung and colorectal tumour cells. Oncogene. 36(44). 6164–6176. 23 indexed citations

10.

Dermit, Maria, Pedro Casado, Vinothini Rajeeve, et al.. (2016). Oxidative stress downstream of mTORC1 but not AKT causes a proliferative defect in cancer cells resistant to PI3K inhibition. Oncogene. 36(19). 2762–2774. 26 indexed citations

11.

Michopoulos, Filippos, Niki Karagianni, Mike Firth, et al.. (2016). Targeted Metabolic Profiling of the Tg197 Mouse Model Reveals Itaconic Acid as a Marker of Rheumatoid Arthritis. Journal of Proteome Research. 15(12). 4579–4590. 36 indexed citations

12.

Pommier, Aurélien, Matthew R. Farren, Bhavika Patel, et al.. (2015). Leptin, BMI, and a Metabolic Gene Expression Signature Associated with Clinical Outcome to VEGF Inhibition in Colorectal Cancer. Cell Metabolism. 23(1). 77–93. 15 indexed citations

13.

Bola, Becky M., Amy L. Chadwick, Filippos Michopoulos, et al.. (2014). Inhibition of Monocarboxylate Transporter-1 (MCT1) by AZD3965 Enhances Radiosensitivity by Reducing Lactate Transport. Molecular Cancer Therapeutics. 13(12). 2805–2816. 155 indexed citations

14.

Ross, Sarah J. & Susan E. Critchlow. (2014). Emerging approaches to target tumor metabolism. Current Opinion in Pharmacology. 17. 22–29. 19 indexed citations

15.

Michopoulos, Filippos, Nicky Whalley, Georgios Theodoridis, et al.. (2014). Targeted profiling of polar intracellular metabolites using ion-pair-high performance liquid chromatography and -ultra high performance liquid chromatography coupled to tandem mass spectrometry: Applications to serum, urine and tissue extracts. Journal of Chromatography A. 1349. 60–68. 70 indexed citations

16.

Polański, Radosław, Cassandra L. Hodgkinson, Alberto Fusi, et al.. (2013). Activity of the Monocarboxylate Transporter 1 Inhibitor AZD3965 in Small Cell Lung Cancer. Clinical Cancer Research. 20(4). 926–937. 282 indexed citations

17.

Finlay, M. Raymond V., David Buttar, Susan E. Critchlow, et al.. (2012). Sulfonyl-morpholino-pyrimidines: SAR and development of a novel class of selective mTOR kinase inhibitor. Bioorganic & Medicinal Chemistry Letters. 22(12). 4163–4168. 27 indexed citations

18.

Floch, Renaud Le, Johanna Chiche, Ibtissam Marchiq, et al.. (2011). CD147 subunit of lactate/H ⁺ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors. Proceedings of the National Academy of Sciences. 108(40). 16663–16668. 354 indexed citations

19.

Critchlow, Susan E., Richard P. Bowater, & Stephen P. Jackson. (1997). Mammalian DNA double-strand break repair protein XRCC4 interacts with DNA ligase IV. Current Biology. 7(8). 588–598. 386 indexed citations

20.

Willmott, Chris, Susan E. Critchlow, Ian C. Eperon, & Anthony Maxwell. (1994). The Complex of DNA Gyrase and Quinolone Drugs with DNA Forms a Barrier to Transcription by RNA Polymerase. Journal of Molecular Biology. 242(4). 351–363. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact